Ethyl bromoacetate → Ethyl 3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-1-piperidineacetate
반응식
[C:1]([O:5][C:6]([NH:8][CH:9]1[CH2:14][CH2:13][CH2:12][NH:11][C:10]1=[O:15])=[O:7])([CH3:4])([CH3:3])[CH3:2].[H-].[Na+].Br[CH2:19][C:20]([O:22][CH2:23][CH3:24])=[O:21]>CN(C)C=O>[C:1]([O:5][C:6]([NH:8][CH:9]1[CH2:14][CH2:13][CH2:12][N:11]([CH2:19][C:20]([O:22][CH2:23][CH3:24])=[O:21])[C:10]1=[O:15])=[O:7])([CH3:4])([CH3:2])[CH3:3]참가 물질
반응 조건
- 온도
- 0 °C
실험 절차
(3RS)-3-tert-butoxycarbonylaminopiperidin-2-one (16.07 g) was dissolved in N,N-dimethylformamide (DMF, 350 ml) and the mixture was cooled to 0° C. Sodium hydride (3.6 g of a 50% dispersion in mineral oil) was added and then the mixture was stirred at 0° C. for one hour. A solution of ethyl bromoacetate (13.78 g) in DMF (20 ml) was then added. The mixture was stirred for 16 hours at ambient temperature, then cooled to 0° C. and ice added. Volatile material was removed by evaporation and the residue was partitioned between ethyl acetate and brine. The organic layer was washed with brine, dried over Na2SO4 and concentrated by evaporation. The resulting oil was purified on silica eluting with 40% ethyl acetate/petroleum ether (60-80° C.) to give ethyl 2-[(3RS)-3-tert-butoxycarbonylamino-2-oxopiperidin-1-yl]acetate as a colourless oil (18.15 g).
후처리
- stirringThe mixture was stirred for 16 hours at ambient temperature
- temperaturecooled to 0° C.
- additionice added
- customVolatile material was removed by evaporation
- customthe residue was partitioned between ethyl acetate and brine
- washThe organic layer was washed with brine
- dry with materialdried over Na2SO4
- concentrationconcentrated by evaporation
- customThe resulting oil was purified on silica eluting with 40% ethyl acetate/petroleum ether (60-80° C.)
출처 및 근거
- ORD 기록
- ord-553aba9a25e1417bae03224d9fd5b172
- 출처 데이터셋
- uspto-grants-2001_02
- 특허 번호
- US06184207B2
반응 노트
불러오는 중…